When hormones are replaced or physiologic levels are restored to those considered normal for younger individuals, men and women experience a dramatic reversal of many symptoms of low hormone levels.1
Testosterone therapy has the potential to slow or halt the progression from metabolic syndrome to overt diabetes or cardiovascular disease due to beneficial effects on insulin regulation, lipid profile and blood pressure.7 Properly administered testosterone replacement therapy, in which estradiol and dihydrotestosterone (DHT) levels are also controlled, has no adverse effects on myocardial infarction risk. Therefore, in men, testosterone replacement therapy is often accompanied by an aromatase inhibitor, such as anastrazole, and a 5α-reductase inhibitor, such as dutasteride or finasteride.8 Hormone balancing for men may also include dehydroepiandrosterone (DHEA), chrysin, zinc, selenium, and other supplements.
Natural testosterone should not be confused with synthetic derivatives or “anabolic steroids,” which have caused disastrous effects when used by athletes and body builders.
Pellet therapy relieves symptoms of hormone deficiency. Busy, active men and women no longer need to worry about remembering to take their medication, there are no unsightly patches, and hormones are not transferred to your loved ones through contact.
Pellet insertion is required only 3 to 4 times per year in order to maintain optimum hormone levels. Pellet insertion is an in-office procedure completed in approximately 20 minutes. Pellets are implanted subcutaneously in the hip or buttocks area. Studies show that pellet therapy improves symptoms of testosterone deficiency, and patients are satisfied with pellet therapy. Side effects are very rare.
LifePlus MD customizes therapy for each man and women. We utilize FDA-approved hormone pellets, or when larger doses are required, our physicians may choose to use pellets that are prepared using testosterone from FDA-inspected suppliers. We carefully select our sources with quality and purity of medications and safety for our patients in mind.
1 Endocrinol Metab Clin North Am 1998 Dec; 27(4):969-87
2 J Clin Endocrinol Metab. 1999 Feb; 84(2):573-7
3 J Clin Psychiatry. 2009 Jul; 70(7):1009-16
4 J Clin Endocrinol Metab. 2000 Aug; 85(8):2839-53
5 J Clin Endocrinol Metab. 2000 Aug; 85(8):2670-7
6 Horm Mol Biol Clin Investig. 2015 Jun; 22(3):111-7
7 J Urol. 2005 Sep; 174(3):827-34
8 Int J Pharm Compd. 2015 May-Jun; 19(3):195-203